[Febrile neutropenia].
作者信息
Takamatsu Yasushi
出版信息
Nihon Rinsho. 2015 Feb;73 Suppl 2:331-5.
PMID:25831777
Abstract
摘要
相似文献
1
[Febrile neutropenia].[发热性中性粒细胞减少症]
Nihon Rinsho. 2015 Feb;73 Suppl 2:331-5.
2
[Antineoplastic drug-induced neutropenia: use of granulocyte colony stimulating factors].[抗肿瘤药物诱导的中性粒细胞减少症：粒细胞集落刺激因子的应用]
Farm Hosp. 2010 Mar;34 Suppl 1:8-11. doi: 10.1016/S1130-6343(10)70002-7.
3
[Fever and neutropenia].
Praxis (Bern 1994). 2013 Oct 30;102(22):1341-8, quiz 1349-50. doi: 10.1024/1661-8157/a001490.
4
Febrile Neutropenia.发热性中性粒细胞减少症
JAMA Oncol. 2017 Dec 1;3(12):1751. doi: 10.1001/jamaoncol.2017.1114.
5
Provider familiarity with specialty society guidelines for risk stratification and management of patients with febrile neutropenia.医疗服务提供者对发热性中性粒细胞减少症患者风险分层和管理的专业学会指南的熟悉程度。
Am J Emerg Med. 2016 Aug;34(8):1704-5. doi: 10.1016/j.ajem.2016.05.047. Epub 2016 May 21.
6
[Infections associated with hematologic diseases].
Rinsho Ketsueki. 2014 Oct;55(10):2208-20.
7
[Primary and secondary prophylactic administration of granulocyte-colony stimulating factor(G-CSF)for febrile neutropenia].[粒细胞集落刺激因子（G-CSF）用于发热性中性粒细胞减少症的一级和二级预防性给药]
Gan To Kagaku Ryoho. 2014 Jun;41(6):691-3.
8
Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors.对临床稳定的发热性中性粒细胞减少症和实体瘤患者进行预后评估时的常见误解。
Clin Transl Oncol. 2019 Aug;21(8):1112-1114. doi: 10.1007/s12094-018-02020-8. Epub 2019 Jan 3.
9
[Breast and Endocrine Tumor Supportive Care for Febrile Neutropenia in Chemotherapy - Current Situation and Future Perspective in Breast Cancer Treatment -].
Gan To Kagaku Ryoho. 2017 Dec;44(13):2072.
10
Hemophagocytic syndrome with febrile neutropenia after chemotherapy.
Intern Med. 2014;53(14):1585-6. doi: 10.2169/internalmedicine.53.2113. Epub 2014 Jul 15.
Zotero 插件